Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
beta-CCM
Potential treatment - theoretical effect Experimental Other treatment Jun/27/2020
Ixazomib
Potential treatment - theoretical effect Used to treat other disease Other treatment Jun/27/2020
Dexanabinol
Potential treatment - theoretical effect Experimental Other treatment Jun/27/2020
Triciribine
Potential treatment - theoretical effect Experimental Other treatment Jun/27/2020
Flubendazole
Potential treatment - theoretical effect Experimental Other treatment Jun/27/2020
Quinoclamine
Potential treatment - theoretical effect Experimental Other treatment Jun/27/2020
Thioflexibilolide A
Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020
Candidine 
Potential treatment - theoretical effect Natural product Antiviral Jun/25/2020
YM201636
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020
VPS34-INI
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020
AZD2014
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020
NVP-BHG712
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/25/2020
Pixatimod
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/24/2020
Opaganib
Potential treatment - clinical evidence Used to treat other disease Antiviral Jun/23/2020
Gabexate
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/23/2020
Bacille Calmette-Guerin vaccine
Potential treatment - clinical evidence Used to treat other disease Vaccine Jun/23/2020
Gliclazide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/20/2020
Memantine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/20/2020
11b
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/19/2020
11a
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/19/2020